Dissolving microneedles to obtain rapid local anesthetic effect of lidocaine at skin tissue

References

• Guy RH. Transdermal drug delivery. In: Schafer-Korting M, ed. Handbook of experimental pharmacology 197 drug delivery. Berlin: Springer; 2004:399–410
   Google Scholar
• Barry B, Williams A. Penetration enhancers. Adv Drug Deliv Rev 2004;56:603–18
   PubMed Web of Science ®Google Scholar
• Cevc G. Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev 2004;56:675–711
   PubMed Web of Science ®Google Scholar
• Preat V, Vanbever R. Skin electroporation for transdermal and topical delivery. Adv Drug Deliv Rev 2004;56:659–74
   PubMed Web of Science ®Google Scholar
• Doukas A. Transdermal delivery with a pressure wave. Adv Drug Deliv Rev 2004;56:559–79
   PubMed Web of Science ®Google Scholar
• Mitragotri S, Kost J. Low-frequency sonophoresis. Adv Drug Deliv Rev 2004;56:589–601
   PubMed Web of Science ®Google Scholar
• Wermeling DP, Banks SL, Hudson DA, et al. Microneedles permit transdermal delivery of a skin-impermeant medication to humans. Proc Natl Acad Sci USA 2008;105:2058–63
   PubMed Web of Science ®Google Scholar
• Cormier M, Johnson B, Ameri M, et al. Transdermal delivery of desmopressin using a coated microneedle array patch system. J Control Release 2004;97:503–11
   PubMed Web of Science ®Google Scholar
• Prausnitz RM. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 2004;56:581–7
   PubMed Web of Science ®Google Scholar
• Levin G, Gershonowitz A, Sacks H, et al. Transdermal delivery of human growth hormone through RF-microchannels. Pharm Res 2005;22:550–5
   PubMed Web of Science ®Google Scholar
• Takada K. Microfabrication derived DDS: From batch to individual production. Drug Discov Ther 2008;2:140–55
   PubMedGoogle Scholar
• Ito Y, Hagiwara E, Saeki A, et al. Feasibility of microneedles for percutaneous absorption of insulin. Eur J Pharm Sci 2006;29:82–8
   PubMed Web of Science ®Google Scholar
• Ito Y, Yoshimitsu J, Shiroyama K, et al. Self-dissolving microneedles for the percutaneous absorption of EPO in mice. J Drug Target 2006;14:255–62
   PubMed Web of Science ®Google Scholar
• Ito Y, Murakami A, Maeda T, et al. Evaluation of self-dissolving needles containing low molecular weight heparin (LMWH) in rats. Int J Pharm 2008;349:124–9
   PubMed Web of Science ®Google Scholar
• Ito Y, Ohashi Y, Shiroyama K, et al. Self-dissolving micropiles for the percutaneous absorption of human growth hormone in rats. Biol Pharm Bull 2008;31:1631–3
   PubMed Web of Science ®Google Scholar
• Ito Y, Saeki A, Shiroyama K, et al. Percutaneous absorption of interferon-α by self-dissolving micropiles. J Drug Target 2008;16:243–9
   PubMed Web of Science ®Google Scholar
• Ito Y, Ohashi Y, Saeki A, et al. Antihyperglycemic effect of insulin from self-dissolving micropiles in dogs. Chem Pharm Bull 2008;56:243–6
   PubMed Web of Science ®Google Scholar
• Bariya SH, Gohel MC, Mehta TA, Sharma OP. Microneedles: an emerging transdermal drug delivery system. J Pharm Pharmacol 2012;64:1–29
   Google Scholar
• Coulman SA, Anstey A, Gateley C, et al. Microneedle mediated delivery of nanoparticles into human skin. Int J Pharm 2009;366:190–200
   PubMed Web of Science ®Google Scholar
• Kalluri H, Banga AK. Microneedles and transdermal drug delivery. J Drug Del Sci Tech 2009;19:303–10
   Web of Science ®Google Scholar
• Singh P, Roberts MS. Dermal and underlying tissue pharmacokinetics of lidocaine after topical application. J Pharm Sci 1994;83:774–82
   PubMed Web of Science ®Google Scholar
• Ito Y, Hamasaki N, Higashino H, et al. Method to increase the systemically delivered amount of drug from dissolving microneedles. Chem Pharm Bull 2013;61:8–15
   PubMed Web of Science ®Google Scholar
• Zhang Y, Siebenaler K, Brown K, et al. Adjuvants to prolong the local anesthetic effects of coated microneedle products. Int J Pharm 2012;439:187–92
   PubMed Web of Science ®Google Scholar
• Zhang Y, Brown K, Siebenaler K, et al. Development of lidocaine-coated microneedle product for rapid, safe, and prolonged local analgesic action. Pharm Res 2012;29:170–7
   PubMed Web of Science ®Google Scholar
• Morawski M, Alpár A, Brückner G, et al. Chondroitin sulfate proteoglycan-based extracellular matrix in chicken (Gallus domesticus) brain. Brain Res 2009;1275:10–23
   PubMed Web of Science ®Google Scholar
• Faissner A, Clement A, Lochter A, et al. Isolation of a neural chondmitin sulfate proteoglycan with neurite outgrowth promoting properties. J Cell Biol 1994;126:783–99
   PubMed Web of Science ®Google Scholar
• Umehara Y, Yamada S, Nishimura S, et al. Chondroitin sulfate of appican, the proteoglycan form of amyloid precursor protein, produced by C6 glioma cells interacts with heparin-binding neuroregulatory factors. FEBS Lett 2004;557:233–8
   PubMed Web of Science ®Google Scholar
• Wilson TM, Snow DM. Chondroitin sulfate proteoglycan expression pattern in hippocampal development: potential regulation of axon tract formation. J Comp Neurol 2000;424:532–46
   PubMed Web of Science ®Google Scholar
• Sintov A, Di-Capua N, Rubinstein A. Cross-linked chondroitin sulfate: characterization for drug delivery purposes. Biomaterials 1995;16:473–8
   PubMed Web of Science ®Google Scholar
• Tsai FM, Chiang LY, Wang FL, et al. Oral sustained delivery of diclofenac sodium using calcium chondroitin sulfate matrix. J Biomater Sci Polym Ed 2005;16:1319–31
   PubMed Web of Science ®Google Scholar